+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 21Years +
All Genders
ID07325266

Study Comparing Two Doses of Apremilast for Treating Moderate to Severe Alcohol Use Disorder

Led by National Institute on Alcohol Abuse and Alcoholism (NIAAA) · Updated on 2026-05-01

100

Participants Needed

3

Research Sites

25 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effects of two different maintenance doses of apremilast tablets on reducing alcohol craving in adults with moderate to severe alcohol use disorder AUD. This phase 2 study aims to compare these doses after two weeks of daily use and also assesses other outcomes such as alcohol consumption, craving, negative consequences, symptoms of AUD, pain, sleep disturbances, depression, anxiety, quality of life, cigarette and nicotine use, cannabis use, study retention, and safety. Participants are randomly assigned to receive either apremilast 60 mg per day, apremilast 90 mg per day, or a matched placebo. The apremilast doses are given in capsules twice daily, with specific capsule counts in the morning and evening. The study uses a triple masking design to compare the effects of these treatments. The treatment period includes daily dosing, and assessments occur over several weeks. During the study, participants complete various assessments including self-reported alcohol use, craving scales, symptom evaluations, and quality of life measures at multiple time points. Laboratory tests include inflammatory marker analysis. Researchers monitor safety and retention throughout the study. The primary outcome measured is alcohol craving at week 4, with additional secondary outcomes recorded up to week 6. Participants are involved in scheduled visits and phone calls as part of the protocol.

CONDITIONS

Brief Title

Human Laboratory Study of Apremilast for Alcohol Use Disorder

Research Team

M

Megan Ryan, MBA

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here